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Abstract  Optic  neuritis  is  an  inﬂammation  of  the  optic  nerve  and  may  be  related  to  different
systemic conditions.  The  clinical  presentation  of  this  pathology  usually  includes  sudden  loss
of visual  acuity  (VA)  which  may  be  unilateral  or  bilateral,  visual  ﬁeld  restriction,  pain  with
eye movements,  dyschromatopsia,  a  relative  afferent  pupillary  defect  and  optic  disk  swelling.
Optic neuritis  in  children  has  speciﬁc  clinical  features  and  a  better  prognosis  than  in  adulthood.
Although  usually  appears  an  underlying  viral  disease,  the  main  concern  for  practitioners  is  the
relationship  of  optic  neuritis  with  multiple  sclerosis.  In  addition  to  the  classical  techniques  as
magnetic resonance  imaging  (MRI),  current  tendencies  of  diagnosis  for  eye  practitioners  include
new imaging  devices  as  optical  coherence  tomography  (OCT),  useful  to  show  a  thinning  of  the
retinal ﬁbers  layer  (RFL)  after  the  inﬂammatory  episode.  Regarding  the  management  of  these
patients, short-term  intravenous  steroid  dosages  seem  to  be  the  best  option  to  treat  acute
attacks characterized  by  a  very  poor  bilateral  VA.
© 2013  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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diferentes  condiciones  sistémicas.  La  presentación  clínica  de  esta  patología  incluye  normal-
mente pérdida  súbita  de  agudeza  visual  (AV),  que  puede  ser  unilateral  o  bilateral,  restricción
del campo  visual,  dolor  al  mover  los  ojos,  discromatopsia  -defecto  pupilar  aferente  relativo-
y edema  del  disco  óptico  del  disco  óptico.  La  neuritis  óptica  en  nin˜os  tiene  características
clínicas  especiales,  y  un  mejor  pronóstico  que  en  los  adultos.  Aunque  normalmente  parece
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una  enfermedad  vírica  subyacente,  la  principal  diﬁcultad  para  los  especialistas  es  la  relación
de la  neuritis  óptica  con  la  esclerosis  múltiple.  Además  de  las  pruebas  clásicas  como  la  res-
onancia magnética  (RM),  las  tendencias  actuales  de  diagnóstico  para  los  profesionales  de  la
salud visual  incluyen  nuevos  dispositivos  de  imagen  tales  como  la  tomografía  de  coherencia
óptica (TCO),  que  es  útil  para  reﬂejar  el  adelgazamiento  de  la  capa  de  ﬁbras  de  la  retina
tras el  episodio  inﬂamatorio.  Respecto  al  tratamiento  de  estos  pacientes,  la  administración  de
esteroides intravenosos  a  corto  plazo  parece  ser  la  mejor  opción  para  tratar  los  ataques  agudos,
caracterizados  por  una  AV  bilateral  muy  reducida.
© 2013  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.  Todos  los
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syphilis,  tuberculosis  or  Lyme  disease).  The  differential  diag-
nosis  of  optic  neuritis  also  includes  optic  neuropathies  of
different  etiologies  such  us  compressive,  ischemic,  heredi-
tary,  toxic  and  nutritional.derechos reservados.
ntroduction
ptic  neuritis  is  a  primary  inﬂammation  of  the  optic  nerve.
linically,  it  can  appear  as  an  isolated  condition  or  asso-
iated  to  a  variety  of  systemic  autoimmune  disorders.  Its
ncidence  is  of  1--5  per  100,000  per  year.1--4 It  mainly  affects
he  Caucasian  population,  most  often  during  the  spring
eriod,  and  especially  to  those  living  at  high  geographic
atitudes.1 Its  origin  is  inﬂammatory  and  the  pathophysi-
logy  of  this  condition  includes  a  peripheral  activation  of
-cells  that  may  cross  the  blood  brain  barrier  causing  a
elayed  type  IV  hypersensitivity  reaction.  This  process  leads
o  destruction  of  myelin,5 with  also  the  involvement  of  the
xon,  something  that  can  be  conﬁrmed  by  mean  of  an  optical
oherence  tomography  (OCT)  examination.  All  this  process
as  a  negative  impact  on  visual  acuity  (VA).6
The  typical  presentation  of  optic  neuritis  is  a  sudden  and
nilateral  visual  loss,  with  VA  ranging  from  levels  of  0.8  in
ecimal  scale  to  no  light  perception  (NPL).  Ninety  percent
f  patients  refer  pain  of  variable  intensity,  usually  perioc-
lar,  which  is  associated  with  ocular  movements  or  may  be
 prelude  of  the  episode  of  optic  neuritis.  The  evolution  of
his  conditions  ranges  from  days  to  weeks  and  is  common  the
ssociation  to  phosphenes  and  ﬂashes  of  light.  Other  clini-
al  ﬁnding  that  can  be  also  associated  with  optic  neuritis  is
he  Uhthoff’  phenomenon  that  consists  on  a  decreased  VA
n  presence  of  a  high  body  temperature  or  during  physical
xercise.1 Likewise,  other  clinical  features  of  optic  neuri-
is  are  abnormal  color  vision,  reduced  contrast  sensitivity
unction,  visual  ﬁeld  loss  characterized  by  central,  paracen-
ral  or  altitudinal  scotomas,  and  the  presence  of  a  relative
fferent  pupillary  defect  (RAPD),  which  is  more  evident  in
nilateral  cases.  In  some  cases,  a  mild  to  moderate  Tyn-
all  effect  may  appear  in  the  anterior  chamber  or  in  the
itreous  as  well  as  a  peripheral  retinal  periphlebitis  (12%  of
atients).  This  last  sign  has  been  proposed  as  an  indicator  of
 greater  probability  of  developing  multiple  sclerosis  (MS).7
n  36--58%  of  patients,  optic  neuritis  is  accompanied  by  papil-
ary  edema  or  optic  head  nerve  swelling,  whereas  in  the  rest
f  cases  inﬂammatory  involvement  occurs  in  the  retrobulbar
ptic  nerve  portion  and,  therefore,  the  appearance  of  the
ptic  nerve  is  normal.8
VA  loss  and  pain  are  limited  in  time  and  occurs  during
he  episode  of  acute  inﬂammation.  From  this  moment,  the
emyelination  and  proliferation  of  sodium  channels  in  the
euronal  segments  begins,  which  is  a  process  that  can  last
ven  more  than  two  years.9 The  same  duration  has  been
eported  for  the  reorganization  of  the  cortical  activation.10
inal  VA  is  in  relation  with  the  severity  of  the  initial  VA
F
e
(oss.  Ninety-four  percent  of  patients  whose  VA  falls  to  less
han  0.6  during  the  episode  of  optic  neuritis  recover  their
revious  VA.  Similarly,  64%  of  patients  whose  VA  drops  to
erception  of  light  (PL)  recovered  a VA  of  0.5  or  better.11
owever,  VA  tends  to  ﬂuctuate  after  an  episode  of  optic
euritis.  Furthermore,  it  is  frequent  the  perception  of  the
hthoff’  phenomenon,  mentioned  above,  and  the  Pullfrich’
henomenon,  which  is  exempliﬁed  with  a  pendulum  seeming
o  describe  an  ellipse  despite  moving  in  a  single  plane,  as  a
esult  of  an  asymmetric  velocity  of  conduction  between  both
ptic  nerves.12 As  RAPD  is  dependent  on  ratio  of  functional
xons  between  both  eyes,  all  these  phenomena  described
ay  remain  in  most  cases  after  the  episode  of  optic  neuri-
is.  Likewise,  pallor  may  remain  normally  in  the  temporal
ortion  of  optic  nerve  (Fig.  1).
The  diagnosis  of  optic  neuritis  is  complex  and  may  lead
o  frequent  errors.1 Optic  neuritis  of  the  adult  is  associ-
ted  with  autoimmune  (Lupus  erythematosus,  sarcoidosis,
ehc¸et’s disease)  and  infectious  diseases  (viral  etiology,igure  1  Optic  disk  temporal  pallor  after  an  episode  of  bilat-
ral optic  neuritis  in  a  13  years-old  patient  with  a  VA  of  0.2
decimal  scale).
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Table  1  Results  of  the  studies  included  in  the  review.
Author  (year)  Study  design  No.  of  patients
analyzed
Average  age
(years)
Bi  (%)  Uni  (%)  VFI  (%)  ONS  (%)
Bonhomme  et  al.  (2009)15 Cohort  29  9.7  ±  3.4  65  34  62  69
Brady et  al.  (1999)19 Cohort  25  9.4  54  45  Not  provided  Not  provided
Waldmann et  al.  (2011)14 Meta-analysis  93  9.5  ±  3.6  55  45  Not  provided  Not  provided
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Presentation and prognosis of optic neuritis in
children
Pediatric  optic  neuritis  is  considered  as  a  different  entity  in
comparison  to  neuritis  that  can  be  found  in  adults.  Gener-
ally,  optic  neuritis  in  the  pediatric  population  has  a  good
prognosis.13,14 It  is  normally  bilateral  and  occurs  after  a
viral  infection  (measles,  mumps,  chicken  pox,  pertussis,
infectious  mononucleosis  and  immunizations).  It  has  also
been  referred  as  a  result  of  a  biotinidase  deﬁciency.15,16
The  clinical  diagnosis  of  the  condition  is  performed  accord-
ing  to  the  following  ﬁndings:  VA  loss,  which  tends  to  be
more  severe  than  in  adulthood,  the  presence  of  moder-
ate  pain  during  activity  of  the  extrinsic  eye  muscles,  RAPD,
dyschromatopsia  and  the  appearance  of  the  optic  nerve
head.
Speciﬁc  studies  on  optic  neuritis  in  children  are  rare,  usu-
ally  heterogeneous  and  with  a  limited  number  of  patients.
A  meta-analysis  conducted  by  Waldman  revealed  that  most
of  studies  about  this  topic  were  observational  (case  con-
trol,  cohort  studies)  or  descriptive  (case  reports,  case  series)
and  that  was  curious  the  lack  of  randomized  clinical  tri-
als  in  the  scientiﬁc  literature.17 Table  1  shows  the  results
of  some  relevant  studies  focused  on  the  classical  features
of  pediatric  optic  neuritis.  The  work  of  Waldman  estab-
lished  a  clear  relationship  between  the  age  and  the  type
of  presentation,  with  a  greater  possibility  of  unilateralism
as  the  age  increases.17 Also,  optic  atrophy  has  been  iden-
tiﬁed  in  85%  of  cases  of  pediatric  optic  neuritis  and  does
not  have  a  strict  correlation  with  VA,20 although  a  pale  disk
at  presentation  is  usually  related  to  a  poorer  visual  out-
come  than  children  with  normal  or  swelling  optic  disk  at
presentation.21
s
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Table  2  Results  of  different  studies  regarding  the  conversion  of  o
Author  (year)  No.  of  patients
analyzed
Rate  of  prog
to MS
Kriss  et  al.  (1988)29 39  15%  
Kennedy et  al.  (1961)30 18  16.5%  
Luchinetti et  al.  (1997)25 79  19%  
Lana-Peixoto  (2001)31 27  4%  
Parkin et  al.  (1984)32 19  5.26%  
Wilejto et  al.  (2006)33 36  36%  
Heussinger  et  al.  (2013)34 34  26.5%  
Sun et  al.  (2011)21 24  12.5%  
Hwang et  al.  (2002)27 23  4.35%  
Mizota et  al.  (2004)28 41  31%  
Abbreviation: MS, multiple sclerosis.nt; ONS, optic nerve swelling.
ptic neuritis and multiple sclerosis
he  clinical  pattern  of  MS  at  any  age  is  characterized  by  both
ensory  and  motor  symptoms  at  onset  and  predominantly
onosymptomatic  presentation  with  a  relapsing-remiting
attern.22 Optic  neuritis  may  be  the  ﬁrst  manifestation  of
S  in  adults  and  children.23 In  adults,  after  an  episode  of
nilateral  optic  neuritis,  the  possibility  of  developing  MS
eaches  38%  in  the  following  10  years.  This  percentage  rises
o  56%  if  there  are  brain  abnormalities  in  magnetic  reso-
ance  imaging  (MRI).24 In  the  pediatric  population,  limited
ata  are  available  and  statistics  are  not  well-established,  as
 result  of  methodological  variability,  bias  and  limitations  of
he  studies  mentioned  above.  The  rate  of  conversion  to  MS
s  not  exactly  delimited  and  different  studies  have  reported
esults  from  4%  to  36%  (Table  2).21,25,29--34 The  largest  sample
ublished  by  Luchinetti  et  al.  reported  that  13%  of  patients
ith  isolated  optic  neuritis  progressed  to  a clinically  or
aboratory-supported  deﬁnite  MS  by  10  years  of  follow-up,
9%  by  20  years,  22%  by  30  years,  and  26%  by  40  years.25 Age
s  also  a  parameter  that  correlates  with  the  increased  risk
or  developing  multiple  sclerosis  (MS)  in  childhood,  probably
s  a  result  of  differential  factors  in  the  immune  system.26
lthough  the  type  of  presentation  (bilateral  vs  unilateral)
s  not  a  factor  in  the  development  of  MS,17 some  authors
ave  found  a  greater  risk  in  those  patients  who  had  sequen-
ial  (with  a  difference  between  both  eyes  of  more  than  2
eeks)  or  recurrent  optic  neuritis  compared  to  those  who
ad  a  single  episode  occurring  in  either  eye  or  both  eyes
imultaneously  (with  a difference  between  both  eyes  of  less
han  2  weeks).17,25
Ethnicity  seems  to  be  another  factor  to  be  considered
n  the  developing  of  MS.  Sun  et  al.  found  a  higher  rate  of
ptic  neuritis  to  multiple  sclerosis.
ression Follow-up  (years)  Country
8.8  England
Not  provided  United  States  of  America
20  United  States  of  America
16  Brazil
26  New  Zealand
2.4  Canada
4.81  Netherlands
11  Taiwan
5  Korea
10.7  Japan
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pisode of  bilateral  optic  neuritis.
rogression  to  MS  after  an  acute  episode  of  optic  neuritis
n  Taiwanese  children  comparing  to  Korean  but  a  lower  rate
omparing  to  Japanese  children.21,27,28
Brain  MRI  is  the  imaging  technique  of  choice  after  a diag-
osis  of  optic  neuritis  and  should  be  performed  preferably
uring  the  following  two  weeks  after  the  initial  symptoms.35
he  absence  of  lesions,  typically  oval  and  located  in  the
eriventricular  white  matter  areas,  is  a  good  prognostic  fac-
or  for  both  the  recovery  of  the  VA  to  the  previous  levels  and
he  decrease  of  the  probability  of  future  development  of  MS.
onhomme  work  suggests  that,  in  the  pediatric  population,
he  risk  for  developing  MS  after  a  ﬁrst  episode  of  optic  neu-
itis  is  higher  if  one  or  more  white  matter  lesions  on  the
o
i
tl  ﬁbers  layer  thinning  in  a  13  years-old  patient  after  an  acute
aseline  MRI  are  present.  In  this  same  work,  the  authors
bserved  that  no  patients  developed  MS  in  the  presence  of
 negative  MRI  at  the  time  of  the  appearance  of  the  episode
f  optic  neuritis.18
Other  diagnostic  tests  that  may  be  used  for  the  diagnosis
f  the  primary  demyelinating  optic  neuritis  are  lumbar  punc-
ure,  visual  evoked  potentials  (VEP)  and  OCT,  which  can  be
seful  to  show  a  thinning  of  the  nerve  ﬁbers  layer  after  an
pisode  of  optic  neuritis36 (Fig.  2).Eye  practitioners  should  be  also  aware  of  neuromyelitis
ptica  (NMO).  This  condition,  also  known  as  Devic  disease,
s  an  autoimmune  disorder  characterized  by  optic  neuri-
is  and  myelitis  that  spares  the  brain  in  early  stages.  The
CT
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ocular  symptoms  of  NMO  include  optic  neuritis,  vision  loss
and  unilateral  or  bilateral  ocular  pain.  It  is  a  much  more
severe  condition  and  causes  a  greater  impairment  than  MS-
associated  optic  neuritis.37
Treatment
The  ONTT  (Optic  Neuritis  Treatment  Trial)  study  was  aimed
to  assess  the  efﬁcacy  of  corticosteroids  for  the  treatment
of  optic  neuritis.  With  this  objective,  three  groups  were
randomized  and  treated  respectively  with  a  combination
of  intravenous  and  oral  steroids  (250  mg  of  methylpred-
nisolone  4  times  a  day  for  3  days  and  oral  prednisolone
1  mg/kg  for  11  days),  only  with  oral  prednisolone  (1  mg/kg
for  14  days)  and  a  third  group  with  a  placebo  substance
for  14  days.  In  adults,  corticosteroid  treatments  did  not
protect  against  recurrences  in  a  follow-up  period  of  3
years,  although  the  recovery  in  the  group  treated  with
intravenous  corticosteroids  was  found  to  be  faster.  Further-
more,  the  group  treated  with  oral  steroids  was  observed
to  have  a  higher  frequency  of  recurrences  during  a  one-
year  follow-up  in  comparison  with  the  other  two  groups.38
This  study,  however,  does  not  include  pediatric  patients
and,  to  the  best  of  our  knowledge,  there  are  no  simi-
lar  clinical  trials  in  this  type  of  population.  Therefore,
the  most  widespread  recommendation  among  authors  for
pediatric  patients  is  conservative  (wait  and  see)  for  uni-
lateral  and  no  severe  bilateral  cases  of  pediatric  optic
neuritis.1,39 Bilateral  cases  with  severe  loss  of  VA  are  rec-
ommended  to  be  treated  with  a  short  dosage  of  intravenous
methylprednisolone  (15  mg/kg/day  for  3  days).1 In  steroid-
resistant  bilateral  optic  neuritis,  plasma  exchange  (PE)  has
been  proposed  as  an  alternative  to  achieve  full  recovery  of
VA.40
In  spite  of  these  guidelines,  eye  practitioners  should
remember  that  acquired  optic  neuropathy  can  occur  from
a  myriad  of  causes,  so  the  prognosis  and  treatment  of
optic  neuritis  also  depends  on  the  underlying  cause.  The
treatment  of  optic  neuritis  requires  ﬁrst  that  the  physician
determine  the  etiology  and  comorbidities  of  the  affected
patient  in  order  to  plan  a  proper  therapeutic  plan.41
Conclusions
Optic  neuritis  is  an  uncommon  condition  in  the  pediatric
population  and  usually  underlies  a  viral  cause.  The  diagno-
sis  is  made  in  the  same  basis  as  in  the  adult  population,
but  its  presentation  is  typically  bilateral,  with  a very
low  VA  and  optic  nerve  swelling.  The  prognosis  is  gener-
ally  good,  especially  when  the  patient  is  younger.  In  the
absence  of  lesions  of  the  white  matter  in  basal  MRI,  the
probability  of  developing  MS  seems  to  be  very  limited.  Treat-
ment  tendencies  consist  of  monitoring,  except  in  bilateral
cases  with  severe  loss  of  VA  where,  under  the  physician’s
criteria,  the  possibility  of  short  dosages  of  intravenous  cor-
ticosteroids  may  be  indicated.  Eye  care  practitioners,  as
primary  care  health  agents,  should  be  aware  of  this  com-
plex  condition  in  order  to  provide  appropriate  information
to  patients  and  for  an  adequate  and  immediate  refer-
ral.129
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